These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 23830367

  • 21. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
    Waters JA, Matos J, Yip-Schneider M, Aguilar-Saavedra JR, Crean CD, Beane JD, Dumas RP, Suvannasankha A, Schmidt CM.
    Surgery; 2015 Oct; 158(4):881-8; discussion 888-9. PubMed ID: 26209568
    [Abstract] [Full Text] [Related]

  • 22. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
    Liu A, Hu YS, Wang ZH, Tang LL, Ke PY, Lin SZ.
    Yao Xue Xue Bao; 2011 Feb; 46(2):146-52. PubMed ID: 21542284
    [Abstract] [Full Text] [Related]

  • 23. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB.
    Cancer Res; 2007 Apr 15; 67(8):3853-61. PubMed ID: 17440100
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of nuclear factor-κB enhances the antitumor effect of tumor necrosis factor-α gene therapy for hepatocellular carcinoma in mice.
    Haruki K, Shiba H, Fujiwara Y, Furukawa K, Iwase R, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    Surgery; 2013 Sep 15; 154(3):468-78. PubMed ID: 23972653
    [Abstract] [Full Text] [Related]

  • 25. Coix seed emulsion synergistically enhances the antitumor activity of gemcitabine in pancreatic cancer through abrogation of NF-κB signaling.
    Qian Y, Yang B, Xiong Y, Gu M.
    Oncol Rep; 2016 Sep 15; 36(3):1517-25. PubMed ID: 27459907
    [Abstract] [Full Text] [Related]

  • 26. {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
    Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Yadav VR, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB.
    Cancer Res; 2010 Nov 01; 70(21):8695-705. PubMed ID: 20864511
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
    Chen D, Niu M, Jiao X, Zhang K, Liang J, Zhang D.
    Int J Mol Sci; 2012 Nov 01; 13(1):1186-1208. PubMed ID: 22312312
    [Abstract] [Full Text] [Related]

  • 28. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.
    Liu C, Shi J, Li Q, Li Z, Lou C, Zhao Q, Zhu Y, Zhan F, Lian J, Wang B, Guan X, Fang L, Li Z, Wang Y, Zhou B, Yao Y, Zhang Y.
    Clin Sci (Lond); 2019 Mar 15; 133(5):645-663. PubMed ID: 30782607
    [Abstract] [Full Text] [Related]

  • 29. Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
    Fujiwara Y, Furukawa K, Haruki K, Shimada Y, Iida T, Shiba H, Uwagawa T, Ohashi T, Yanaga K.
    J Hepatobiliary Pancreat Sci; 2011 Sep 15; 18(5):731-9. PubMed ID: 21484229
    [Abstract] [Full Text] [Related]

  • 30. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
    Ju HQ, Li H, Tian T, Lu YX, Bai L, Chen LZ, Sheng H, Mo HY, Zeng JB, Deng W, Chiao PJ, Xu RH.
    J Pineal Res; 2016 Jan 15; 60(1):27-38. PubMed ID: 26445000
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
    Wang FT, Wang H, Wang QW, Pan MS, Li XP, Sun W, Fan YZ.
    Cancer Chemother Pharmacol; 2020 Aug 15; 86(2):221-232. PubMed ID: 32654071
    [Abstract] [Full Text] [Related]

  • 32. Enhanced antitumor effect of combination therapy with gemcitabine and guggulsterone in pancreatic cancer.
    Ahn DW, Seo JK, Lee SH, Hwang JH, Lee JK, Ryu JK, Kim YT, Yoon YB.
    Pancreas; 2012 Oct 15; 41(7):1048-57. PubMed ID: 22513291
    [Abstract] [Full Text] [Related]

  • 33. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
    Liu J, Ma J, Wu Z, Li W, Zhang D, Han L, Wang F, Reindl KM, Wu E, Ma Q.
    BMC Cancer; 2014 Sep 20; 14():686. PubMed ID: 25240403
    [Abstract] [Full Text] [Related]

  • 34. [An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA].
    Kong R, Sun B, Wang SJ, Pan SH, Wang G, Chen H, Xue DB, Jiang HC.
    Zhonghua Wai Ke Za Zhi; 2010 Jan 15; 48(2):128-33. PubMed ID: 20302733
    [Abstract] [Full Text] [Related]

  • 35. [Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer].
    Wang SJ, Sun B, Pan SH, Chen H, Kong R, Li J, Xue DB, Bai XW, Jiang HC.
    Zhonghua Wai Ke Za Zhi; 2010 Apr 01; 48(7):530-4. PubMed ID: 20646665
    [Abstract] [Full Text] [Related]

  • 36. Insulin-like growth factor 1 receptor promotes the growth and chemoresistance of pancreatic cancer.
    Tian X, Hao K, Qin C, Xie K, Xie X, Yang Y.
    Dig Dis Sci; 2013 Sep 01; 58(9):2705-12. PubMed ID: 23589145
    [Abstract] [Full Text] [Related]

  • 37. Effects and mechanisms of the combination of suberoylanilide hydroxamic acid and bortezomib on the anticancer property of gemcitabine in pancreatic cancer.
    Lee JK, Ryu JK, Yang KY, Woo SM, Park JK, Yoon WJ, Lee SH, Jeong KS, Kim YT, Yoon YB.
    Pancreas; 2011 Aug 01; 40(6):966-73. PubMed ID: 21487323
    [Abstract] [Full Text] [Related]

  • 38. NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activation.
    Zhuang Z, Li H, Lee H, Aguilar M, Gocho T, Ju H, Iida T, Ling J, Fu J, Wu M, Sun Y, Lu Y, Chiao PJ.
    Cancer Lett; 2017 Dec 28; 411():44-56. PubMed ID: 28951128
    [Abstract] [Full Text] [Related]

  • 39. PARP14 promotes the proliferation and gemcitabine chemoresistance of pancreatic cancer cells through activation of NF-κB pathway.
    Yao N, Chen Q, Shi W, Tang L, Fu Y.
    Mol Carcinog; 2019 Jul 28; 58(7):1291-1302. PubMed ID: 30968979
    [Abstract] [Full Text] [Related]

  • 40. Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.
    Guo HC, Bu HQ, Luo J, Wei WT, Liu DL, Chen H, Tong HF, Wang ZH, Wu HY, Li HH, Zuo MM, Li W, Lin SZ.
    Int J Oncol; 2012 Jun 28; 40(6):1849-57. PubMed ID: 22378302
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.